| High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis SE Schindler, JG Bollinger, V Ovod, KG Mawuenyega, Y Li, BA Gordon, ... Neurology 93 (17), e1647-e1659, 2019 | 799 | 2019 |
| Cholesterol-dependent γ-secretase activity in buoyant cholesterol-rich membrane microdomains S Wahrle, P Das, AC Nyborg, C McLendon, M Shoji, T Kawarabayashi, ... Neurobiology of disease 9 (1), 11-23, 2002 | 550 | 2002 |
| ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE SE Wahrle, H Jiang, M Parsadanian, J Legleiter, X Han, JD Fryer, ... Journal of Biological Chemistry 279 (39), 40987-40993, 2004 | 542 | 2004 |
| Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease SE Wahrle, H Jiang, M Parsadanian, J Kim, A Li, A Knoten, S Jain, ... The Journal of clinical investigation 118 (2), 671-682, 2008 | 459 | 2008 |
| Deletion of Abca1 increases Aβ deposition in the PDAPP transgenic mouse model of Alzheimer disease SE Wahrle, H Jiang, M Parsadanian, RE Hartman, KR Bales, SM Paul, ... Journal of Biological Chemistry 280 (52), 43236-43242, 2005 | 399 | 2005 |
| Assessment of racial disparities in biomarkers for Alzheimer disease JC Morris, SE Schindler, LM McCue, KL Moulder, TLS Benzinger, ... JAMA neurology 76 (3), 264-273, 2019 | 309 | 2019 |
| Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging SE Schindler, JD Gray, BA Gordon, C Xiong, R Batrla-Utermann, M Quan, ... Alzheimer's & Dementia 14 (11), 1460-1469, 2018 | 248 | 2018 |
| Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease LM Shaw, J Arias, K Blennow, D Galasko, JL Molinuevo, S Salloway, ... Alzheimer's & Dementia 14 (11), 1505-1521, 2018 | 226 | 2018 |
| Validation of plasma amyloid-β 42/40 for detecting Alzheimer disease amyloid plaques Y Li, SE Schindler, JG Bollinger, V Ovod, KG Mawuenyega, MW Weiner, ... Neurology 98 (7), e688-e699, 2022 | 166 | 2022 |
| Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease AL Ferreiro, JH Choi, J Ryou, EP Newcomer, R Thompson, RM Bollinger, ... Science translational medicine 15 (700), eabo2984, 2023 | 151 | 2023 |
| Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Aβ42 accumulation in amyloid model mice CV Zerbinatti, SE Wahrle, H Kim, JA Cam, K Bales, SM Paul, ... Journal of Biological Chemistry 281 (47), 36180-36186, 2006 | 151 | 2006 |
| Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-β M Morikawa, JD Fryer, PM Sullivan, EA Christopher, SE Wahrle, ... Neurobiology of disease 19 (1-2), 66-76, 2005 | 147 | 2005 |
| Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests NR Barthélemy, G Salvadó, SE Schindler, Y He, S Janelidze, LE Collij, ... Nature medicine 30 (4), 1085-1095, 2024 | 146 | 2024 |
| Effect of race on prediction of brain amyloidosis by plasma Aβ42/Aβ40, phosphorylated tau, and neurofilament light SE Schindler, TK Karikari, NJ Ashton, RL Henson, KE Yarasheski, T West, ... Neurology 99 (3), e245-e257, 2022 | 112 | 2022 |
| Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape H Hampel, Y Hu, J Cummings, S Mattke, T Iwatsubo, A Nakamura, ... Neuron 111 (18), 2781-2799, 2023 | 111 | 2023 |
| CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease K Horie, G Salvadó, NR Barthélemy, S Janelidze, Y Li, Y He, B Saef, ... Nature medicine 29 (8), 1954-1963, 2023 | 105 | 2023 |
| Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1polymorphisms SE Wahrle, AR Shah, AM Fagan, S Smemo, JSK Kauwe, A Grupe, ... Molecular neurodegeneration 2, 1-9, 2007 | 102 | 2007 |
| Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy K Yanamandra, TK Patel, H Jiang, S Schindler, JD Ulrich, AL Boxer, ... Science translational medicine 9 (386), eaal2029, 2017 | 99 | 2017 |
| Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease SE Schindler, Y Li, KW Todd, EM Herries, RL Henson, JD Gray, G Wang, ... Alzheimer's & Dementia 15 (5), 655-665, 2019 | 97 | 2019 |
| ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes A Soldan, C Pettigrew, AM Fagan, SE Schindler, A Moghekar, C Fowler, ... Neurology 92 (14), e1567-e1579, 2019 | 96 | 2019 |
Tammie L.S. Benzinger, MD, PhDProfessor of Radiology and Neurosurgery, Washington University School of Medicine in Saint Louiswustl.edu의 이메일 확인됨